Table 3.
Conservative group | Surgical group | p-value | |
---|---|---|---|
NSAIDs | |||
During previous 4 weeks | 46 (96) | 44 (92) | 0.399 |
At 6-week follow-up | 45 (94) | 40 (83) | 0.109 |
At 3-month follow-up | 42 (88) | 7 (15) | < 0.001 |
At 6-month follow-up | 44 (92) | 2 (4) | < 0.001 |
Opioids | |||
During previous 4 weeks | 24 (50) | 29 (60) | 0.305 |
At 6-week follow-up | 34 (71) | 23 (48) | 0.022 |
At 3-month follow-up | 27 (56) | 3 (6) | < 0.001 |
At 6-month follow-up | 19 (38) | 1 (2) | < 0.001 |
Pregabalin or gabapentin | |||
During previous 4 weeks | 27 (56) | 34 (71) | 0.138 |
At 6-week follow-up | 28 (58) | 15 (31) | 0.008 |
At 3-month follow-up | 26 (54) | 4 (8) | < 0.001 |
At 6-month follow-up | 24 (50) | 2 (4) | < 0.001 |
Sleep medication | |||
During previous 4 weeks | 12 (25) | 11 (23) | 0.811 |
Type of sleep medication | 0.307 | ||
Hypnotics | 8 | 5 | |
Benzodiazepine | 3 | 4 | |
Anti-depressant | 1 | 2 | |
At 6-week follow-up | 12 (25) | 11 (23) | 0.811 |
At 3-month follow-up | 13 (27) | 11 (23) | 0.637 |
At 6-month follow-up | 14 (29) | 10 (21) | 0.346 |
Data were presented by number (%) of patients or mean ± standard deviation.